Literature DB >> 18770131

Active and passive immunisation against nephritis induced by an avian infectious bronchitis virus.

J W Macdonald1, C J Randall, D A McMartin, M D Dagless, P Gazdzinski.   

Abstract

Intranasal vaccination with the H120 strain of infectious bronchitis virus (IBV) produced serum neutralisation indices of three or more in nine out of 12 birds. This afforded complete protection against intravenous challenge with the nephritogenic H52 strain of IBV and prevented the multiplication of virus in the kidney. Passive immunisation with homologous convalescent serum protected the kidney but not the respiratory tract against similar challenge. The frequency of virus isolations from the kidney was reduced, the agar gel precipitin response lowered and the haemagglutination inhibition response abolished.

Entities:  

Year:  1981        PMID： 18770131     DOI： 10.1080/03079458108418466

Source DB:  PubMed          Journal:  Avian Pathol        ISSN： 0307-9457            Impact factor:   3.378


  5 in total

1.  The efficacy of the prime-boost regimen for heterologous infectious bronchitis vaccines mandates the administration of homologous vaccines.

Authors:  Anwar A G Al-Kubati; Maged Gomaa Hemida; Abdullah I A Al-Mubarak
Journal:  Virusdisease       Date:  2022-08-29

2.  Infectious bronchitis virus: Immunopathogenesis of infection in the chicken.

Authors:  G D Raj; R C Jones
Journal:  Avian Pathol       Date:  1997       Impact factor: 3.378

3.  Evaluation of the protection conferred by commercial vaccines and attenuated heterologous isolates in China against the CK/CH/LDL/97I strain of infectious bronchitis coronavirus.

Authors:  Shengwang Liu; Xiaonan Zhang; Yu Wang; Chengren Li; Qiaoran Liu; Zongxi Han; Qinxia Zhang; Xiangang Kong; Guangzhi Tong
Journal:  Vet J       Date:  2007-11-01       Impact factor: 2.688

Review 4.  Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus.

Authors:  Dave Cavanagh
Journal:  Avian Pathol       Date:  2003-12       Impact factor: 3.378

5.  A DNA prime-protein boost vaccination strategy targeting turkey coronavirus spike protein fragment containing neutralizing epitope against infectious challenge.

Authors:  Yi-Ning Chen; Ching Ching Wu; Yoon Yeo; Peisheng Xu; Tsang Long Lin
Journal:  Vet Immunol Immunopathol       Date:  2013-02-01       Impact factor: 2.046
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.